Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Vaccines
|
February 28, 2023
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
Tammie Choi, Bryan Chan, Lisa Grech, et al.
Vaccines
|
September 23, 2022
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
Nathan Bain, Mike Nguyen, Lisa Grech, et al.
Cell Metabolism
|
December 3, 2025
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
Iyassu K Sebhat, Monika J M Murphy, Shuqin Zheng, et al.
Communications Biology
|
October 9, 2023
Author Correction: COSMOS: a platform for real-time morphology-based, label-free cell sorting using deep learning
Mahyar Salek, Nianzhen Li, Hou-Pu Chou, et al.
Communications Biology
|
September 22, 2023
COSMOS: a platform for real-time morphology-based, label-free cell sorting using deep learning
Mahyar Salek, Nianzhen Li, Hou-Pu Chou, et al.
Vaccines
|
June 24, 2022
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
Daphne Day, Lisa Grech, Mike Nguyen, et al.
Journal of Medicinal Chemistry
|
July 25, 2025
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
Christopher R Moyes, Shuwen He, Simon Mathieu, et al.
Journal of Medicinal Chemistry
|
March 12, 2016
Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
Robert Heald, Krista K Bowman, Marian C Bryan, et al.
Journal of Medicinal Chemistry
|
October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
Robert Heald, Krista K Bowman, Marian C Bryan, et al.
Nature Communications
|
June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model
Thijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Vaccines
|
February 28, 2023
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
Tammie Choi, Bryan Chan, Lisa Grech, et al.
Vaccines
|
September 23, 2022
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
Nathan Bain, Mike Nguyen, Lisa Grech, et al.
Cell Metabolism
|
December 3, 2025
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
Iyassu K Sebhat, Monika J M Murphy, Shuqin Zheng, et al.
Communications Biology
|
October 9, 2023
Author Correction: COSMOS: a platform for real-time morphology-based, label-free cell sorting using deep learning
Mahyar Salek, Nianzhen Li, Hou-Pu Chou, et al.
Communications Biology
|
September 22, 2023
COSMOS: a platform for real-time morphology-based, label-free cell sorting using deep learning
Mahyar Salek, Nianzhen Li, Hou-Pu Chou, et al.
Vaccines
|
June 24, 2022
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
Daphne Day, Lisa Grech, Mike Nguyen, et al.
Journal of Medicinal Chemistry
|
July 25, 2025
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
Christopher R Moyes, Shuwen He, Simon Mathieu, et al.
Journal of Medicinal Chemistry
|
March 12, 2016
Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
Robert Heald, Krista K Bowman, Marian C Bryan, et al.
Journal of Medicinal Chemistry
|
October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
Robert Heald, Krista K Bowman, Marian C Bryan, et al.
Nature Communications
|
June 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model
Thijs J Hagenbeek, Jason Zbieg, Russell Smith, et al.
Page
of 3